Follicular Drug Eruption Induced by Gefitinib (ZD 1839, Iressa): Clinical Picture Correlates with in vitro Data of Focal Epidermal Necrosis after Epidermal Growth Factor Inhibition in Skin Cultures

Publisher： Karger

E-ISSN： 1421-9832|211|4|375-376

ISSN： 1018-8665

Source： Dermatology, Vol.211, Iss.4, 2005-12, pp. : 375-376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Exfoliative Eruption Secondary to Gefitinib (ZD1839)

By  

Dermatology, Vol. 215, Iss. 3, 2007-09 ,pp. : 266-268

Karger

Access to resources Recommend Favorite

Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Acneiform Eruption with Topical Recombinant Human Epidermal Growth Factor

By  

Dermatology, Vol. 225, Iss. 2, 2012-09 ,pp. : 135-140

Karger

Access to resources Recommend Favorite

Development of Multiple Paronychia and Periungual Granulation in Patients Treated with Gefitinib, an Inhibitor of Epidermal Growth Factor Receptor

By  

Dermatology, Vol. 207, Iss. 3, 2003-10 ,pp. : 324-325

Karger

Access to resources Recommend Favorite

Factor-XIIIa-Positive Dendrocytes in Drug-Induced Toxic Epidermal Necrolysis (Lyell’s Syndrome): Paradoxical Activation in Skin and Rarefaction in Lymph Nodes

By  

Dermatology, Vol. 206, Iss. 4, 2003-06 ,pp. : 374-378

Karger

Access to resources Recommend Favorite

Azithromycin Pulses for the Treatment of Epidermal Growth Factor Receptor Inhibitor-Related Papulopustular Eruption: An Effective and Convenient Alternative to Tetracyclines

By  

Dermatology, Vol. 224, Iss. 4, 2012-06 ,pp. : 315-319

Karger

Access to resources Recommend Favorite